<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2d1 20170631//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article" dtd-version="1.2d1" specific-use="production" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">BIORXIV</journal-id>
<journal-title-group>
<journal-title>bioRxiv</journal-title>
<abbrev-journal-title abbrev-type="publisher">bioRxiv</abbrev-journal-title>
</journal-title-group>
<publisher>
<publisher-name>Cold Spring Harbor Laboratory</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1101/223677</article-id>
<article-version>1.1</article-version>
<article-categories>
<subj-group subj-group-type="author-type">
<subject>Regular Article</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Contradictory Results</subject>
</subj-group>
<subj-group subj-group-type="hwp-journal-coll">
<subject>Microbiology</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Cooperating H3N2 influenza virus variants are not detectable in primary clinical samples</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4094-3615</contrib-id>
<name>
<surname>Xue</surname>
<given-names>Katherine S.</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Greninger</surname>
<given-names>Alexander L.</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>P&#x00E9;rez-Osorio</surname>
<given-names>Ailyn</given-names>
</name>
<xref ref-type="aff" rid="a5">5</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1267-3408</contrib-id>
<name>
<surname>Bloom</surname>
<given-names>Jesse D.</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="corresp" rid="cor1">&#x0023;</xref>
</contrib>
<aff id="a1"><label>1</label><institution>Department of Genome Sciences, University of Washington</institution>, Seattle, <country>United States</country></aff>
<aff id="a2"><label>2</label><institution>Division of Basic Sciences and Computational Biology Program, Fred Hutchinson Cancer Research Center</institution>, Seattle, <country>United States</country></aff>
<aff id="a3"><label>3</label><institution>Department of Laboratory Medicine, University of Washington</institution>, Seattle, <country>United States</country></aff>
<aff id="a4"><label>4</label><institution>Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center</institution>, Seattle, <country>United States</country></aff>
<aff id="a5"><label>5</label><institution>Washington State Department of Health, Public Health Laboratories</institution>, Shoreline, <country>United States</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>&#x0023;</label>Corresponding author: <email>jbloom@fredhutch.org</email></corresp>
</author-notes>
<pub-date pub-type="epub"><year>2017</year></pub-date>
<elocation-id>223677</elocation-id>
<history>
<date date-type="received">
<day>21</day>
<month>11</month>
<year>2017</year>
</date>
<date date-type="rev-recd">
<day>21</day>
<month>11</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>23</day>
<month>11</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2017, Posted by Cold Spring Harbor Laboratory</copyright-statement>
<copyright-year>2017</copyright-year>
<license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This pre-print is available under a Creative Commons License (Attribution 4.0 International), CC BY 4.0, as described at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link></license-p></license>
</permissions>
<self-uri xlink:href="223677.pdf" content-type="pdf" xlink:role="full-text"/>
<abstract>
<title>ABSTRACT</title>
<p>The high mutation rates of RNA viruses lead to rapid genetic diversification, which can enable cooperative interactions between variants in a viral population. We previously described two distinct variants of H3N2 influenza virus that cooperate in cell culture. These variants differ by a single mutation, D151G, in the neuraminidase protein. The D151G mutation reaches a stable frequency of about 50&#x0025; when virus is passaged in cell culture. However, it is unclear whether selection for the cooperative benefits of D151G is a cell-culture phenomenon, or whether the mutation is also sometimes present at appreciable frequency in virus populations sampled directly from infected humans. Prior work has not detected D151G in unpassaged clinical samples, but these studies have used methods like Sanger sequencing and pyrosequencing that are relatively insensitive to low-frequency variation. We identified nine samples of human H3N2 influenza collected between 2013 to 2015 in which Sanger sequencing had detected a high frequency of the D151G mutation following one to three passages in cell culture. We deep-sequenced the unpassaged clinical samples to identify low-frequency viral variants. The frequency of D151G did not exceed the frequency of library preparation and sequencing errors in any of the sequenced samples. We conclude that passage in cell culture is primarily responsible for the frequent observations of D151G in recent H3N2 influenza strains.</p>
<sec>
<title>IMPORTANCE</title>
<p>Viruses mutate rapidly, and recent studies of RNA viruses have shown that related viral variants can sometimes cooperate to improve each other&#x2019;s growth. We previously described two variants of H3N2 influenza virus that cooperate in cell culture. The mutation responsible for cooperation is often observed when human samples of influenza virus are grown in the lab before sequencing, but it is unclear whether the mutation also exists in human infections or is exclusively the result of lab passage. We identified nine human isolates of influenza that had developed the cooperating mutation after being grown in the lab, and performed highly sensitive deep-sequencing of the unpassaged clinical samples to determine whether the mutation existed in the original human infections. We found no evidence of the cooperating mutation in the unpassaged samples, suggesting that the cooperation primarily arises in laboratory conditions.</p>
</sec>
</abstract>
<counts>
<page-count count="11"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1">
<title>INTRODUCTION</title>
<p>RNA viruses like influenza mutate rapidly to form genetically diverse quasispecies. Several recent studies have suggested that interactions between different variants in a quasispecies can promote overall population fitness. In poliovirus, variants generated through spontaneous mutation are important for neurotropism, innate immune suppression, and overall pathogenesis in mouse models (<xref ref-type="bibr" rid="c1">1</xref>&#x2013;<xref ref-type="bibr" rid="c3">3</xref>). Other groups have identified cooperative interactions in measles virus (<xref ref-type="bibr" rid="c4">4</xref>), West Nile virus (<xref ref-type="bibr" rid="c5">5</xref>), hepatitis B virus (<xref ref-type="bibr" rid="c6">6</xref>), and Coxsackie virus (<xref ref-type="bibr" rid="c7">7</xref>). These cooperative interactions have primarily been observed in cell culture or animal models rather than clinical infections.</p>
<p>We previously described two distinct variants of H3N2 influenza virus that cooperate in cell culture (<xref ref-type="bibr" rid="c8">8</xref>). The two variants differ by a single mutation at amino acid 151 of neuraminidase (NA), the protein that releases new virions from host cells. The D151 viral variant, typically encoded as <monospace>GAT</monospace>, predominates among clinical influenza samples, and it grows robustly in cell culture. The G151 viral variant, typically encoded as <monospace>GGT</monospace>, binds sialic-acid receptors rather than cleaving them (<xref ref-type="bibr" rid="c9">9</xref>, <xref ref-type="bibr" rid="c10">10</xref>) and grows extremely poorly in isolation. However, a mixed population of D151 and G151 viral variants outgrows either single variant in cell culture.</p>
<p>An important question is whether cooperation between these two viral variants is purely a cell-culture phenomenon, or whether the D151 and G151 variants co-exist in natural infections. The D151G mutation is frequently observed when influenza virus is passaged through cell culture (<xref ref-type="bibr" rid="c9">9</xref>, <xref ref-type="bibr" rid="c11">11</xref>&#x2013;<xref ref-type="bibr" rid="c16">16</xref>), but it remains unclear whether the G151 variant exists within natural human infections or is primarily a cell-culture artifact. Prior groups that have performed matched clinical sequencing of unpassaged and passaged clinical samples have failed to detect the G151 variant before passaging (<xref ref-type="bibr" rid="c13">13</xref>, <xref ref-type="bibr" rid="c15">15</xref>), but these studies have used methods like Sanger sequencing and pyrosequencing that are relatively insensitive to rare variation. More sensitive characterization of clinical samples that give rise to D151G upon lab passage can determine whether this mutation reaches high frequencies in cell culture because it is amplified from low&#x002D; to modest-frequency standing diversity, or whether it arises spontaneously in the lab.</p>
<p>We sought to determine whether the D151G mutation is present in viral populations isolated from natural human infections. We identified nine clinical samples that, based on prior Sanger sequencing, consisted of a mixture of D151 and G151 viruses after passage in cell culture. We deep-sequenced the original unpassaged nasal swab samples to survey the variation present prior to laboratory growth. The D151G mutation did not exceed the frequency of library preparation and sequencing errors in any of these samples. These results suggest that most variation observed at site 151 results from passage in cell culture rather than standing variation in human infections.</p>
</sec>
<sec id="s2">
<title>RESULTS</title>
<p>Most influenza-virus sequences in public databases are determined by Sanger sequencing of clinical isolates that have been passaged one or more times in cell culture (<xref ref-type="bibr" rid="c17">17</xref>). A substantial number of recent human H3N2 influenza virus sequences in these databases contain an ambiguous nucleotide at NA site 151 because the lab-passaged samples often converge to a mix of the D151 and G151 variants (<xref ref-type="bibr" rid="c8">8</xref>). We sought to compare passaged samples that contained this ambiguous nucleotide at site 151 to unpassaged samples from the same viral infections. We first identified strains from western Washington state in the GISAID EpiFlu database (<xref ref-type="bibr" rid="c18">18</xref>) for which Sanger sequencing had reported an ambiguous nucleotide at NA site 151 corresponding to a mix of the D151 and G151 variants (<xref ref-type="bibr" rid="c8">8</xref>). Based on the annotations available in the GISAID EpiFlu database, most of these strains had been passaged in cell culture prior to Sanger sequencing.</p>
<p>We obtained original, unpassaged nasal swab samples for the nine strains in <xref ref-type="table" rid="tbl1">Table 1</xref> that contained a mixture of D151 and G151 variants after passage in cell culture. These samples had been collected between 2013 and 2015 and had undergone one to three passages in cell culture prior to sequencing. We performed whole-genome sequencing of the influenza genome from the unpassaged clinical samples using influenza-specific reverse transcription and PCR (<xref ref-type="bibr" rid="c19">19</xref>). For each sample, we prepared sequencing libraries in duplicate, beginning from separate reverse-transcription reactions (<xref ref-type="bibr" rid="c20">20</xref>). We sequenced each viral sample to an average sequencing depth of 100x-10,000x (<xref ref-type="fig" rid="fig1">Figure 1</xref>), allowing us to observe viral variants at frequencies below the limit of detection of Sanger sequencing or pyrosequencing.</p>
<fig id="fig1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1:</label>
<caption><title>Sequencing coverage along the influenza genome.</title>
<p>Average sequencing coverage is plotted for 50 bp bins across the genome, with library replicates shown in solid and dashed lines.</p></caption>
<graphic xlink:href="223677_fig1.tif"/>
</fig>
<table-wrap id="tbl1" orientation="portrait" position="float">
<label>Table 1</label>
<caption><title>Strains deep-sequenced in this study.</title>
<p>Genotypes were determined through Sanger sequencing of passaged isolates, and are taken from those reported in the GISAID EpiFlu database. Annotations of passage history are not standardized, but C[N] generally refers to N passages of the virus in cell culture prior to sequencing, and S[N] generally refers to N passages of the virus in MDCK-SIAT1 cells (<xref ref-type="bibr" rid="c17">17</xref>). For the genotype at site 151, an annotation of X indicates a mix of D151 and G151 in the original Sanger sequencing. The Ct value is the amount of viral material in the original clinical sample as determined by qPCR.</p></caption>
<graphic xlink:href="223677_tbl1.tif"/>
</table-wrap>
<p>We identified all minor viral variants present at a frequency of at least 3&#x0025; in the viral genome in both library replicates (<xref ref-type="table" rid="tbl2">Table 2</xref>). We did not observe the D151G variant in any of the nine clinical samples under these variant-calling criteria. To ensure that we were not missing extremely low-frequency variation, we calculated the frequency of D151G in each clinical sample based on the frequency of G-to-A mutations at the second nucleotide position of NA site 151. We compared this frequency to the frequency of G-to-A mutations at other sites across the genome (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Minor-variant frequencies at NA site 151 fell well within the range of error expected through library preparation and sequencing errors. Therefore, we conclude that the D151G variant was not present at appreciable frequencies in the original clinical infections. Instead, the mutation must have arisen <italic>de novo</italic> or been enriched from an extremely low frequency during passage in cell culture.</p>
<table-wrap id="tbl2" orientation="portrait" position="float">
<label>Table 2</label>
<caption><title>Within-host variants identified through deep sequencing</title>
<p>Sites were called as variable if a non-consensus base exceeded a frequency of 0.03, given a sequencing coverage of at least 100x, in both sequencing replicates.</p></caption>
<graphic xlink:href="223677_tbl2.tif"/>
</table-wrap>
<fig id="fig2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2:</label>
<caption><title>D151G does not exceed the frequency of library preparation and sequencing errors in unpassaged clinical samples.</title>
<p>Shown is the distribution of frequencies of G-to-A mutations across the genome for each clinical sample. Typically, the D151 viral variant is encoded by the nucleotides <monospace>GAT</monospace>, and the G151 variant is encoded as <monospace>GGT</monospace>, meaning that D151G arises as the result of a G-to-A mutation. The red vertical line shows the proportion of G-to-A mutations at codon position 2 of amino-acid site 151 of NA, which corresponds to the frequency of D151G. In cases where no G-to-A mutations were identified at this site, this red line is not shown. At each nucleotide site in the genome with consensus identity G, we calculated the total proportion of reads reporting an identity of A at that site and averaged this proportion between both replicate libraries. As expected, G-to-A mutations make up less than 0.1&#x0025; of total sequencing reads at most sites in the genome and are probably errors introduced through library preparation and sequencing.</p></caption>
<graphic xlink:href="223677_fig2.tif"/>
</fig>
</sec>
<sec id="s3">
<title>DISCUSSION</title>
<p>The results of our deep-sequencing study support prior studies that failed to detect the D151G mutation in unpassaged clinical samples using Sanger sequencing or pyrosequencing methods (<xref ref-type="bibr" rid="c13">13</xref>, <xref ref-type="bibr" rid="c15">15</xref>). In the GISAID EpiFlu database, mixed populations of D151 and G151 viral variants are common in clinical samples that have been passaged in cell culture, but these mixed populations are rare among unpassaged and egg-passaged populations (<xref ref-type="bibr" rid="c8">8</xref>). It is impossible to rule out the possibility that the D151G mutation reaches appreciable frequencies in some natural human infections, but strong and repeated selection for cooperation in cell culture seems to account for its prevalence among sequences in public databases.</p>
<p>It is interesting to speculate about what biological factors might cause a variant that is rare in natural human infections to be strongly selected in cell culture. Influenza strains often acquire stereotypical mutations when they are grown in eggs (<xref ref-type="bibr" rid="c21">21</xref>, <xref ref-type="bibr" rid="c22">22</xref>), but these passage adaptations appear to be less common in cell culture, particularly for <monospace>MdCk-SIAT</monospace>1 cells (<xref ref-type="bibr" rid="c17">17</xref>, <xref ref-type="bibr" rid="c23">23</xref>). Nevertheless, differences in the types and distributions of cell-surface receptors between MDCK-SIAT1 cells and human airways could account for some of the differences in genotypes we observe at NA site 151.</p>
<p>We also previously observed that cooperation is stronger at high multiplicities of infection (MOI) (<xref ref-type="bibr" rid="c8">8</xref>). Viral load can be high during natural infections (<xref ref-type="table" rid="tbl1">Table 1</xref>), but recent studies of natural human infections have found that the effective reassortment rate is limited, suggesting that spatial heterogeneity within the host may limit viral circulation and co-infection (<xref ref-type="bibr" rid="c24">24</xref>). Moreover, human influenza infections, as well as those in animal models (<xref ref-type="bibr" rid="c25">25</xref>), experience a severe transmission bottleneck that greatly limits the genetic diversity initially present in an infection (<xref ref-type="bibr" rid="c26">26</xref>&#x2013;<xref ref-type="bibr" rid="c28">28</xref>). In contrast, viral populations can rapidly reach high MOIs in cell culture (<xref ref-type="bibr" rid="c29">29</xref>). These different growth conditions may also promote the emergence of D151G within cell culture, but not natural infections.</p>
<p>Our study also underscores the importance of sequencing directly from unpassaged clinical samples. Mutations like D151G accumulate in cell culture within just a few passages and affect downstream analyses like inferences of positive selection (<xref ref-type="bibr" rid="c17">17</xref>). Careful records of passage histories combined with deep-sequencing of unpassaged clinical samples can help distinguish natural variation from that generated in the lab.</p>
</sec>
<sec id="s4">
<title>MATERIALS AND METHODS</title>
<sec id="s4a">
<title>Viral samples</title>
<p>We downloaded the set of 66 sequences in the Global Initiative on Sharing All Influenza Data (GISAID) EpiFlu database (<xref ref-type="bibr" rid="c18">18</xref>) corresponding to all full-length NA coding regions from human H3N2 influenza A isolates collected from January 1, 2000 to August 26, 2015 and submitted from Seattle, Washington, or Shoreline, Washington (<bold>Table S1</bold>). We pairwise aligned each sequence to the A/Hanoi/Q118/2007 (H3N2) coding sequence (Genbank accession CY104446) using the program needle from EMBOSS version 6.6.0 (<xref ref-type="bibr" rid="c30">30</xref>). For each sequence, we determined the genotype at site 151 and assigned the genotype X if there was an ambiguous nucleotide at that site. We identified sequences with ambiguous identities at site 151, suggesting the presence of mixed viral populations, and we extracted passage histories based on the metadata available in the GISAID Epiflu database. For the nine strains described in <xref ref-type="table" rid="tbl1">Table 1</xref>, we were able to obtain aliquots of the original, unpassaged nasal swab samples in viral transport media.</p>
</sec>
<sec id="s4b">
<title>Viral deep sequencing</title>
<p>We performed viral deep sequencing as previously described (<xref ref-type="bibr" rid="c19">19</xref>). In brief, we extracted viral RNA from unpassaged clinical samples using the QIAamp Viral RNA Mini Kit (Qiagen) according to manufacturer&#x2019;s instructions. We reverse-transcribed the viral RNA using the Superscript III First-Strand Reaction Mix (Thermo Fisher) and an equimolar mix of the influenza-specific primers 5&#x2032;-TATTGGTCTCAGGGAGCAAAAGCAGG-3&#x2032; and 5&#x2032;-TATTGGTCTCAGGGAGCGAAAGCAGG-3&#x2032;, which both bind to the conserved U12 region at one end of each influenza gene. The two primers differ by a single nucleotide to account for a known polymorphism in the region. We incubated the reverse-transcription reactions at 25 degrees C for 10 minutes (to help the short primer anneal), 50 degrees C for 50 minutes, and 85 degrees C for 5 minutes. We amplified the influenza genome using a mixture of 24 primers that bind to the ends of each influenza gene (<xref ref-type="bibr" rid="c31">31</xref>). For each gene, one primer binds to the conserved U13 region at one end of the gene, and two primers bind to the conserved U12 region at the other end of the gene, allowing for the known polymorphism in the U12 region. We performed 35 cycles of PCR using an annealing temperature of 55 degrees C and an extension time of 3 minutes. We purified the PCR product using 1X AMPure beads (Beckman Coulter) and prepared libraries for Illumina sequencing using Nextera XT (Illumina) tagmentation. We sequenced the libraries on a NextSeq 500 platform (Illumina) with 150 bp paired-end reads. We performed all library preparation and sequencing in duplicate, starting from independent reverse-transcription reactions (<xref ref-type="bibr" rid="c20">20</xref>).</p>
</sec>
<sec id="s4c">
<title>Analysis of deep-sequencing data</title>
<p>We first used bowtie2 (<xref ref-type="bibr" rid="c32">32</xref>) to filter out reads that mapped to the human genome. Remaining reads are available in the SRA as BioProject PRJNA412675. We trimmed adapters from the raw reads using cutadapt version 1.8.3 (<xref ref-type="bibr" rid="c33">33</xref>). We first aligned the reads to the A/Victoria/361/2011 genome using bowtie2 and the &#x2013; <monospace>very-sensitive</monospace> setting, then we used custom scripts to generate a new consensus genome sequence for each viral sample. We then re-aligned the reads to the corresponding consensus sequence and removed PCR duplicates using picard version 1.43. We used custom scripts to filter out base calls with a quality score below 20, tally the total number of high-quality bases at each genome position, and annotate each variant&#x2019;s codon position. We performed these initial analyses separately for each replicate library. We reported only variants that were located in protein-coding sequence.</p>
</sec>
<sec id="s4d">
<title>A note on codon numbering and gene annotation</title>
<p>We numbered HA codons according to the H3 numbering system. This HA numbering scheme assigns 1 to codon 17 of the full HA gene, which is the beginning of the mature HA protein. The codons for all other genes are numbered sequentially beginning with one at the N-terminal methionine. The M1 and M2 genes have 27 bp of in-frame and 44 bp of out-of-frame overlap, and the NS1 and NEP genes have 30 bp of in-frame and 251 bp of out-of-frame overlap. We annotated variants separately for each gene if they occurred in these regions of overlap.</p>
</sec>
<sec id="s4e">
<title>Data and code availability</title>
<p>Sequencing reads are available on the SRA as BioProject PRJNA412675. The computer code that performs the analyses is available on Github at <ext-link ext-link-type="uri" xlink:href="https://github.com/ksxue/D151G-clinical-public">https://github.com/ksxue/D151G-clinical-public</ext-link>.</p>
</sec>
</sec>
</body>
<back>
<ack>
<title>ACKNOWLEDGEMENTS</title>
<p>This study was funded by R01GM102198 from the NIGMS, R01AI127893 from the NIAID, a Howard Hughes Medical Institute Faculty Scholar Award, and a Simons Foundation Faculty Scholar Award to JDB. KSX was funded by an NSF Graduate Research Fellowship under grant number DGE-1256082 and a graduate fellowship from the Fannie and John Hertz Foundation. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="c1"><label>1</label><mixed-citation publication-type="journal"><string-name><surname>Pfeiffer</surname> <given-names>JK</given-names></string-name>, <string-name><surname>Kirkegaard</surname> <given-names>K.</given-names></string-name> <year>2005</year>. <article-title>Increased fidelity reduces poliovirus fitness and virulence under selective pressure in mice</article-title>. <source>PLoS Pathog</source> <volume>1</volume>: <fpage>e11</fpage>.</mixed-citation></ref>
<ref id="c2"><label>2</label><mixed-citation publication-type="journal"><string-name><surname>Vignuzzi</surname> <given-names>M</given-names></string-name>, <string-name><surname>Stone</surname> <given-names>JK</given-names></string-name>, <string-name><surname>Arnold</surname> <given-names>JJ</given-names></string-name>, <string-name><surname>Cameron</surname> <given-names>CE</given-names></string-name>, <string-name><surname>Andino</surname> <given-names>R.</given-names></string-name> <year>2006</year>. <article-title>Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population</article-title>. <source>Nature</source> <volume>439</volume>: <fpage>344</fpage>&#x2013;<lpage>8</lpage>.</mixed-citation></ref>
<ref id="c3"><label>3</label><mixed-citation publication-type="journal"><string-name><surname>Xiao</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Dolan</surname> <given-names>PT</given-names></string-name>, <string-name><surname>Goldstein</surname> <given-names>EF</given-names></string-name>, <string-name><surname>Li</surname> <given-names>M</given-names></string-name>, <string-name><surname>Farkov</surname> <given-names>M</given-names></string-name>, <string-name><surname>Brodsky</surname> <given-names>L</given-names></string-name>, <string-name><surname>Andino</surname> <given-names>R.</given-names></string-name> <year>2017</year>. <article-title>Poliovirus intrahost evolution is required to overcome tissue-specific innate immune responses</article-title>. <source>Nat Commun</source> <volume>8</volume>: <fpage>375</fpage>.</mixed-citation></ref>
<ref id="c4"><label>4</label><mixed-citation publication-type="journal"><string-name><surname>Shirogane</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Watanabe</surname> <given-names>S</given-names></string-name>, <string-name><surname>Yanagi</surname> <given-names>Y.</given-names></string-name> <year>2012</year>. <article-title>Cooperation between different RNA virus genomes produces a new phenotype</article-title>. <source>Nat Commun</source> <volume>3</volume>: <fpage>1235</fpage>.</mixed-citation></ref>
<ref id="c5"><label>5</label><mixed-citation publication-type="journal"><string-name><surname>Ciota</surname> <given-names>AT</given-names></string-name>, <string-name><surname>Ehrbar</surname> <given-names>DJ</given-names></string-name>, <string-name><surname>Van Slyke</surname> <given-names>GA</given-names></string-name>, <string-name><surname>Willsey</surname> <given-names>GG</given-names></string-name>, <string-name><surname>Kramer</surname> <given-names>LD.</given-names></string-name> <year>2012</year>. <article-title>Cooperative interactions in the West Nile virus mutant swarm</article-title>. <source>BMC Evol Biol</source> <volume>12</volume>: <fpage>58</fpage>.</mixed-citation></ref>
<ref id="c6"><label>6</label><mixed-citation publication-type="journal"><string-name><surname>Cao</surname> <given-names>L</given-names></string-name>, <string-name><surname>Wu</surname> <given-names>C</given-names></string-name>, <string-name><surname>Shi</surname> <given-names>H</given-names></string-name>, <string-name><surname>Gong</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>E</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>H</given-names></string-name>, <string-name><surname>Zhao</surname> <given-names>K</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>S</given-names></string-name>, <string-name><surname>Li</surname> <given-names>S</given-names></string-name>, <string-name><surname>Gao</surname> <given-names>X</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Pei</surname> <given-names>R</given-names></string-name>, <string-name><surname>Lu</surname> <given-names>M</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>X.</given-names></string-name> <year>2014</year>. <article-title>Coexistence of hepatitis B virus quasispecies enhances viral replication and the ability to induce host antibody and cellular immune responses</article-title>. <source>J Virol</source> <volume>88</volume>: <fpage>8656</fpage>&#x2013;<lpage>66</lpage>.</mixed-citation></ref>
<ref id="c7"><label>7</label><mixed-citation publication-type="journal"><string-name><surname>Border&#x00ED;a</surname> <given-names>A V</given-names></string-name>, <string-name><surname>Isakov</surname> <given-names>O</given-names></string-name>, <string-name><surname>Moratorio</surname> <given-names>G</given-names></string-name>, <string-name><surname>Henningsson</surname> <given-names>R</given-names></string-name>, <string-name><surname>Ag&#x00FC;era-Gonz&#x00E1;lez</surname> <given-names>S</given-names></string-name>, <string-name><surname>Organtini</surname> <given-names>L</given-names></string-name>, <string-name><surname>Gn&#x00E4;dig</surname> <given-names>NF</given-names></string-name>, <string-name><surname>Blanc</surname> <given-names>H</given-names></string-name>, <string-name><surname>Alcover</surname> <given-names>A</given-names></string-name>, <string-name><surname>Hafenstein</surname> <given-names>S</given-names></string-name>, <string-name><surname>Fontes</surname> <given-names>M</given-names></string-name>, <string-name><surname>Shomron</surname> <given-names>N</given-names></string-name>, <string-name><surname>Vignuzzi</surname> <given-names>M.</given-names></string-name> <year>2015</year>. <article-title>Group Selection and Contribution of Minority Variants during Virus Adaptation Determines Virus Fitness and Phenotype</article-title>. <source>PLoS Pathog</source> <volume>11</volume>: <fpage>e1004838</fpage>.</mixed-citation></ref>
<ref id="c8"><label>8</label><mixed-citation publication-type="journal"><string-name><surname>Xue</surname> <given-names>KS</given-names></string-name>, <string-name><surname>Hooper</surname> <given-names>KA</given-names></string-name>, <string-name><surname>Ollodart</surname> <given-names>AR</given-names></string-name>, <string-name><surname>Dingens</surname> <given-names>AS</given-names></string-name>, <string-name><surname>Bloom</surname> <given-names>JD.</given-names></string-name> <year>2016</year>. <article-title>Cooperation between distinct viral variants promotes growth of h3n2 influenza in cell culture</article-title>. <source>Elife</source> <volume>5</volume>.</mixed-citation></ref>
<ref id="c9"><label>9</label><mixed-citation publication-type="journal"><string-name><surname>Lin</surname> <given-names>YP</given-names></string-name>, <string-name><surname>Gregory</surname> <given-names>V</given-names></string-name>, <string-name><surname>Collins</surname> <given-names>P</given-names></string-name>, <string-name><surname>Kloess</surname> <given-names>J</given-names></string-name>, <string-name><surname>Wharton</surname> <given-names>S</given-names></string-name>, <string-name><surname>Cattle</surname> <given-names>N</given-names></string-name>, <string-name><surname>Lackenby</surname> <given-names>A</given-names></string-name>, <string-name><surname>Daniels</surname> <given-names>R</given-names></string-name>, <string-name><surname>Hay</surname> <given-names>A.</given-names></string-name> <year>2010</year>. <article-title>Neuraminidase receptor binding variants of human influenza A(H3N2) viruses resulting from substitution of aspartic acid 151 in the catalytic site: a role in virus attachment?</article-title> <source>J Virol</source> <volume>84</volume>: <fpage>6769</fpage>&#x2013;<lpage>6781</lpage>.</mixed-citation></ref>
<ref id="c10"><label>10</label><mixed-citation publication-type="journal"><string-name><surname>Zhu</surname> <given-names>X</given-names></string-name>, <string-name><surname>McBride</surname> <given-names>R</given-names></string-name>, <string-name><surname>Nycholat</surname> <given-names>CM</given-names></string-name>, <string-name><surname>Yu</surname> <given-names>W</given-names></string-name>, <string-name><surname>Paulson</surname> <given-names>JC</given-names></string-name>, <string-name><surname>Wilson</surname> <given-names>I a</given-names></string-name>. <year>2012</year>. <article-title>Influenza virus neuraminidases with reduced enzymatic activity that avidly bind sialic acid receptors</article-title>. <source>J Virol</source> <volume>86</volume>: <fpage>13371</fpage>&#x2013;<lpage>13383</lpage>.</mixed-citation></ref>
<ref id="c11"><label>11</label><mixed-citation publication-type="journal"><string-name><surname>McKimm-Breschkin</surname> <given-names>J</given-names></string-name>, <string-name><surname>Trivedi</surname> <given-names>T</given-names></string-name>, <string-name><surname>Hampson</surname> <given-names>A</given-names></string-name>, <string-name><surname>Hay</surname> <given-names>A</given-names></string-name>, <string-name><surname>Klimov</surname> <given-names>A</given-names></string-name>, <string-name><surname>Tashiro</surname> <given-names>M</given-names></string-name>, <string-name><surname>Hayden</surname> <given-names>F</given-names></string-name>, <string-name><surname>Zambon</surname> <given-names>M.</given-names></string-name> <year>2003</year>. <article-title>Neuraminidase Sequence Analysis and Susceptibilities of Influenza Virus Clinical Isolates to Zanamivir and Oseltamivir</article-title>. <source>Antimicrob Agents Chemother</source> <volume>47</volume>: <fpage>2264</fpage>&#x2013;<lpage>2272</lpage>.</mixed-citation></ref>
<ref id="c12"><label>12</label><mixed-citation publication-type="journal"><string-name><surname>Tamura</surname> <given-names>D</given-names></string-name>, <string-name><surname>Nguyen</surname> <given-names>HT</given-names></string-name>, <string-name><surname>Sleeman</surname> <given-names>K</given-names></string-name>, <string-name><surname>Levine</surname> <given-names>M</given-names></string-name>, <string-name><surname>Mishin</surname> <given-names>VP</given-names></string-name>, <string-name><surname>Yang</surname> <given-names>H</given-names></string-name>, <string-name><surname>Guo</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Okomo-Adhiambo</surname> <given-names>M</given-names></string-name>, <string-name><surname>Xu</surname> <given-names>X</given-names></string-name>, <string-name><surname>Stevens</surname> <given-names>J</given-names></string-name>, <string-name><surname>Gubareva</surname> <given-names>L V.</given-names></string-name> <year>2013</year>. <article-title>Cell culture-selected substitutions in influenza A(H3N2) neuraminidase affect drug susceptibility assessment</article-title>. <source>Antimicrob Agents Chemother</source> <volume>57</volume>: <fpage>6141</fpage>&#x2013;<lpage>6</lpage>.</mixed-citation></ref>
<ref id="c13"><label>13</label><mixed-citation publication-type="journal"><string-name><surname>Lee</surname> <given-names>HK</given-names></string-name>, <string-name><surname>Tang</surname> <given-names>JW-T</given-names></string-name>, <string-name><surname>Kong</surname> <given-names>DH-L</given-names></string-name>, <string-name><surname>Loh</surname> <given-names>TP</given-names></string-name>, <string-name><surname>Chiang</surname> <given-names>DK-L</given-names></string-name>, <string-name><surname>Lam</surname> <given-names>TT-Y</given-names></string-name>, <string-name><surname>Koay</surname> <given-names>ES-C.</given-names></string-name> <year>2013</year>. <article-title>Comparison of mutation patterns in full-genome A/H3N2 influenza sequences obtained directly from clinical samples and the same samples after a single MDCK passage</article-title>. <source>PLoS One</source> <volume>8</volume>: <fpage>e79252</fpage>.</mixed-citation></ref>
<ref id="c14"><label>14</label><mixed-citation publication-type="journal"><string-name><surname>Chambers</surname> <given-names>BS</given-names></string-name>, <string-name><surname>Li</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Hodinka</surname> <given-names>RL</given-names></string-name>, <string-name><surname>Hensley</surname> <given-names>SE.</given-names></string-name> <year>2014</year>. <article-title>Recent H3N2 influenza virus clinical isolates rapidly acquire hemagglutinin or neuraminidase mutations when propagated for antigenic analyses</article-title>. <source>J Virol</source> <volume>88</volume>: <fpage>10986</fpage>&#x2013;<lpage>9</lpage>.</mixed-citation></ref>
<ref id="c15"><label>15</label><mixed-citation publication-type="journal"><string-name><surname>Mishin</surname> <given-names>VP</given-names></string-name>, <string-name><surname>Sleeman</surname> <given-names>K</given-names></string-name>, <string-name><surname>Levine</surname> <given-names>M</given-names></string-name>, <string-name><surname>Carney</surname> <given-names>PJ</given-names></string-name>, <string-name><surname>Stevens</surname> <given-names>J</given-names></string-name>, <string-name><surname>Gubareva</surname> <given-names>L V.</given-names></string-name> <year>2014</year>. <article-title>The effect of the MDCK cell selected neuraminidase D151G mutation on the drug susceptibility assessment of influenza A(H3N2) viruses</article-title>. <source>Antiviral Res</source> <volume>101</volume>: <fpage>93</fpage>&#x2013;<lpage>96</lpage>.</mixed-citation></ref>
<ref id="c16"><label>16</label><mixed-citation publication-type="journal"><string-name><surname>Mohr</surname> <given-names>PG</given-names></string-name>, <string-name><surname>Deng</surname> <given-names>Y-M</given-names></string-name>, <string-name><surname>McKimm-Breschkin</surname> <given-names>JL.</given-names></string-name> <year>2015</year>. <article-title>The neuraminidases of MDCK grown human influenza A(H3N2) viruses isolated since 1994 can demonstrate receptor binding</article-title>. <source>Virol J</source> <volume>12</volume>: <fpage>67</fpage>.</mixed-citation></ref>
<ref id="c17"><label>17</label><mixed-citation publication-type="journal"><string-name><surname>McWhite</surname> <given-names>CD</given-names></string-name>, <string-name><surname>Meyer</surname> <given-names>AG</given-names></string-name>, <string-name><surname>Wilke</surname> <given-names>CO.</given-names></string-name> <year>2016</year>. <article-title>Sequence amplification via cell passaging creates spurious signals of positive adaptation in influenza virus H3N2 hemagglutinin</article-title>. <source>Virus Evol</source> <volume>2</volume>: vew<fpage>026</fpage>.</mixed-citation></ref>
<ref id="c18"><label>18</label><mixed-citation publication-type="journal"><string-name><surname>Bogner</surname> <given-names>P</given-names></string-name>, <string-name><surname>Capua</surname> <given-names>I</given-names></string-name>, <string-name><surname>Lipman</surname> <given-names>DJ</given-names></string-name>, <string-name><surname>Cox</surname> <given-names>NJ.</given-names></string-name> <year>2006</year>. <article-title>A global initiative on sharing avian flu data</article-title>. <source>Nature</source> <volume>442</volume>: <fpage>981</fpage>&#x2013;<lpage>981</lpage>.</mixed-citation></ref>
<ref id="c19"><label>19</label><mixed-citation publication-type="journal"><string-name><surname>Xue</surname> <given-names>KS</given-names></string-name>, <string-name><surname>Stevens-Ayers</surname> <given-names>T</given-names></string-name>, <string-name><surname>Campbell</surname> <given-names>AP</given-names></string-name>, <string-name><surname>Englund</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Pergam</surname> <given-names>SA</given-names></string-name>, <string-name><surname>Boeckh</surname> <given-names>M</given-names></string-name>, <string-name><surname>Bloom</surname> <given-names>JD.</given-names></string-name> <year>2017</year>. <article-title>Parallel evolution of influenza across multiple spatiotemporal scales</article-title>. <source>Elife</source> <volume>6</volume>.</mixed-citation></ref>
<ref id="c20"><label>20</label><mixed-citation publication-type="journal"><string-name><surname>McCrone</surname> <given-names>JT</given-names></string-name>, <string-name><surname>Lauring</surname> <given-names>AS.</given-names></string-name> <year>2016</year>. <article-title>Measurements of Intrahost Viral Diversity Are Extremely Sensitive to Systematic Errors in Variant Calling</article-title>. <source>J Virol</source> <volume>90</volume>: <fpage>6884</fpage>&#x2013;<lpage>6895</lpage>.</mixed-citation></ref>
<ref id="c21"><label>21</label><mixed-citation publication-type="journal"><string-name><surname>Brand</surname> <given-names>C</given-names></string-name>, <string-name><surname>Palese</surname> <given-names>P.</given-names></string-name> <year>1980</year>. <article-title>Sequential passage of influenza virus in embryonated eggs or tissue culture: Emergence of mutants</article-title>. <source>Virology</source> <volume>107</volume>: <fpage>424</fpage>&#x2013;<lpage>433</lpage>.</mixed-citation></ref>
<ref id="c22"><label>22</label><mixed-citation publication-type="journal"><string-name><surname>Skowronski</surname> <given-names>DM</given-names></string-name>, <string-name><surname>Janjua</surname> <given-names>NZ</given-names></string-name>, <string-name><surname>De Serres</surname> <given-names>G</given-names></string-name>, <string-name><surname>Sabaiduc</surname> <given-names>S</given-names></string-name>, <string-name><surname>Eshaghi</surname> <given-names>A</given-names></string-name>, <string-name><surname>Dickinson</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Fonseca</surname> <given-names>K</given-names></string-name>, <string-name><surname>Winter</surname> <given-names>A-L</given-names></string-name>, <string-name><surname>Gubbay</surname> <given-names>JB</given-names></string-name>, <string-name><surname>Krajden</surname> <given-names>M</given-names></string-name>, <string-name><surname>Petric</surname> <given-names>M</given-names></string-name>, <string-name><surname>Charest</surname> <given-names>H</given-names></string-name>, <string-name><surname>Bastien</surname> <given-names>N</given-names></string-name>, <string-name><surname>Kwindt</surname> <given-names>TL</given-names></string-name>, <string-name><surname>Mahmud</surname> <given-names>SM</given-names></string-name>, <string-name><surname>Van Caeseele</surname> <given-names>P</given-names></string-name>, <string-name><surname>Li</surname> <given-names>Y.</given-names></string-name> <year>2014</year>. <article-title>Low 2012&#x2013;13 Influenza Vaccine Effectiveness Associated with Mutation in the Egg-Adapted H3N2 Vaccine Strain Not Antigenic Drift in Circulating Viruses</article-title>. <source>PLoS One</source> <volume>9</volume>: <fpage>e92153</fpage>.</mixed-citation></ref>
<ref id="c23"><label>23</label><mixed-citation publication-type="journal"><string-name><surname>Oh</surname> <given-names>DY</given-names></string-name>, <string-name><surname>Barr</surname> <given-names>IG</given-names></string-name>, <string-name><surname>Mosse</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Laurie</surname> <given-names>KL.</given-names></string-name> <year>2008</year>. <article-title>MDCK-SIAT1 cells show improved isolation rates for recent human influenza viruses compared to conventional MDCK cells</article-title>. <source>J Clin Microbiol</source> <volume>46</volume>: <fpage>2189</fpage>&#x2013;<lpage>94</lpage>.</mixed-citation></ref>
<ref id="c24"><label>24</label><mixed-citation publication-type="journal"><string-name><surname>Sobel Leonard</surname> <given-names>A</given-names></string-name>, <string-name><surname>McClain</surname> <given-names>MT</given-names></string-name>, <string-name><surname>Smith</surname> <given-names>GJD</given-names></string-name>, <string-name><surname>Wentworth</surname> <given-names>DE</given-names></string-name>, <string-name><surname>Halpin</surname> <given-names>RA</given-names></string-name>, <string-name><surname>Lin</surname> <given-names>X</given-names></string-name>, <string-name><surname>Ransier</surname> <given-names>A</given-names></string-name>, <string-name><surname>Stockwell</surname> <given-names>TB</given-names></string-name>, <string-name><surname>Das</surname> <given-names>SR</given-names></string-name>, <string-name><surname>Gilbert</surname> <given-names>AS</given-names></string-name>, <string-name><surname>Lambkin-Williams</surname> <given-names>R</given-names></string-name>, <string-name><surname>Ginsburg</surname> <given-names>GS</given-names></string-name>, <string-name><surname>Woods</surname> <given-names>CW</given-names></string-name>, <string-name><surname>Koelle</surname> <given-names>K</given-names></string-name>, <string-name><surname>Illingworth</surname> <given-names>CJR.</given-names></string-name> <year>2017</year>. <article-title>The effective rate of influenza reassortment is limited during human infection</article-title>. <source>PLOS Pathog</source> <volume>13</volume>: <fpage>e1006203</fpage>.</mixed-citation></ref>
<ref id="c25"><label>25</label><mixed-citation publication-type="journal"><string-name><surname>Varble</surname> <given-names>A</given-names></string-name>, <string-name><surname>Albrecht</surname> <given-names>RA</given-names></string-name>, <string-name><surname>Backes</surname> <given-names>S</given-names></string-name>, <string-name><surname>Crumiller</surname> <given-names>M</given-names></string-name>, <string-name><surname>Bouvier</surname> <given-names>NM</given-names></string-name>, <string-name><surname>Sachs</surname> <given-names>D</given-names></string-name>, <string-name><surname>Garc&#x00ED;a-Sastre</surname> <given-names>A</given-names></string-name>, <string-name><surname>tenOever</surname> <given-names>BR.</given-names></string-name> <year>2014</year>. <article-title>Influenza A virus transmission bottlenecks are defined by infection route and recipient host</article-title>. <source>Cell Host Microbe</source> <volume>16</volume>: <fpage>691</fpage>&#x2013;<lpage>700</lpage>.</mixed-citation></ref>
<ref id="c26"><label>26</label><mixed-citation publication-type="journal"><string-name><surname>Poon</surname> <given-names>LLM</given-names></string-name>, <string-name><surname>Song</surname> <given-names>T</given-names></string-name>, <string-name><surname>Rosenfeld</surname> <given-names>R</given-names></string-name>, <string-name><surname>Lin</surname> <given-names>X</given-names></string-name>, <string-name><surname>Rogers</surname> <given-names>MB</given-names></string-name>, <string-name><surname>Zhou</surname> <given-names>B</given-names></string-name>, <string-name><surname>Sebra</surname> <given-names>R</given-names></string-name>, <string-name><surname>Halpin</surname> <given-names>RA</given-names></string-name>, <string-name><surname>Guan</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Twaddle</surname> <given-names>A</given-names></string-name>, <string-name><surname>DePasse</surname> <given-names>J V</given-names></string-name>, <string-name><surname>Stockwell</surname> <given-names>TB</given-names></string-name>, <string-name><surname>Wentworth</surname> <given-names>DE</given-names></string-name>, <string-name><surname>Holmes</surname> <given-names>EC</given-names></string-name>, <string-name><surname>Greenbaum</surname> <given-names>B</given-names></string-name>, <string-name><surname>Peiris</surname> <given-names>JSM</given-names></string-name>, <string-name><surname>Cowling</surname> <given-names>BJ</given-names></string-name>, <string-name><surname>Ghedin</surname> <given-names>E.</given-names></string-name> <year>2016</year>. <article-title>Quantifying influenza virus diversity and transmission in humans</article-title>. <source>Nat Genet</source> <volume>48</volume>: <fpage>195</fpage>&#x2013;<lpage>200</lpage>.</mixed-citation></ref>
<ref id="c27"><label>27</label><mixed-citation publication-type="journal"><string-name><surname>Sobel Leonard</surname> <given-names>A</given-names></string-name>, <string-name><surname>Weissman</surname> <given-names>DB</given-names></string-name>, <string-name><surname>Greenbaum</surname> <given-names>B</given-names></string-name>, <string-name><surname>Ghedin</surname> <given-names>E</given-names></string-name>, <string-name><surname>Koelle</surname> <given-names>K.</given-names></string-name> <year>2017</year>. <article-title>Transmission Bottleneck Size Estimation from Pathogen Deep-Sequencing Data, with an Application to Human Influenza A Virus</article-title>. <source>J Virol</source> <volume>91</volume>: <issue>JVI</issue>. <fpage>00171</fpage>&#x2013;<lpage>17</lpage>.</mixed-citation></ref>
<ref id="c28"><label>28</label><mixed-citation publication-type="other"><string-name><surname>McCrone</surname> <given-names>JT</given-names></string-name>, <string-name><surname>Woods</surname> <given-names>RJ</given-names></string-name>, <string-name><surname>Martin</surname> <given-names>ET</given-names></string-name>, <string-name><surname>Malosh</surname> <given-names>RE</given-names></string-name>, <string-name><surname>Monto</surname> <given-names>AS</given-names></string-name>, <string-name><surname>Lauring</surname> <given-names>AS.</given-names></string-name> <year>2017</year>. <article-title>The evolutionary dynamics of influenza A virus within and between human hosts</article-title>. doi. <pub-id pub-id-type="doi">org 176362</pub-id>.</mixed-citation></ref>
<ref id="c29"><label>29</label><mixed-citation publication-type="journal"><string-name><surname>Novella</surname> <given-names>IS</given-names></string-name>, <string-name><surname>Reissig</surname> <given-names>DD</given-names></string-name>, <string-name><surname>Wilke</surname> <given-names>CO.</given-names></string-name> <year>2004</year>. <article-title>Density-dependent selection in vesicular stomatitis virus</article-title>. <source>J Virol</source> <volume>78</volume>: <fpage>5799</fpage>&#x2013;<lpage>804</lpage>.</mixed-citation></ref>
<ref id="c30"><label>30</label><mixed-citation publication-type="journal"><string-name><surname>Rice</surname> <given-names>P</given-names></string-name>, <string-name><surname>Longden</surname> <given-names>I</given-names></string-name>, <string-name><surname>Bleasby</surname> <given-names>A.</given-names></string-name> <year>2000</year>. <article-title>EMBOSS: The European Molecular Biology Open Software Suite</article-title>. <source>Trends Genet</source> <volume>16</volume>: <fpage>276</fpage>&#x2013;<lpage>277</lpage>.</mixed-citation></ref>
<ref id="c31"><label>31</label><mixed-citation publication-type="journal"><string-name><surname>Hoffmann</surname> <given-names>E</given-names></string-name>, <string-name><surname>Stech</surname> <given-names>J</given-names></string-name>, <string-name><surname>Guan</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Webster</surname> <given-names>RG</given-names></string-name>, <string-name><surname>Perez</surname> <given-names>DR.</given-names></string-name> <year>2001</year>. <article-title>Universal primer set for the full-length amplification of all influenza A viruses</article-title>. <source>Arch Virol</source> <volume>146</volume>: <fpage>2275</fpage>&#x2013;<lpage>2289</lpage>.</mixed-citation></ref>
<ref id="c32"><label>32</label><mixed-citation publication-type="journal"><string-name><surname>Langmead</surname> <given-names>B</given-names></string-name>, <string-name><surname>Salzberg</surname> <given-names>SL.</given-names></string-name> <year>2012</year>. <article-title>Fast gapped-read alignment with Bowtie 2</article-title>. <source>Nat Methods</source> <volume>9</volume>: <fpage>357</fpage>&#x2013;<lpage>359</lpage>.</mixed-citation></ref>
<ref id="c33"><label>33</label><mixed-citation publication-type="journal"><string-name><surname>Martin</surname> <given-names>M.</given-names></string-name> <year>2011</year>. <article-title>Cutadapt removes adapter sequences from high-throughput sequencing reads</article-title>. <source>EMBnet. journal</source> <volume>17</volume>: <fpage>10</fpage>.</mixed-citation></ref>
</ref-list>
</back>
</article>